Medtronic Stock: Buy, Sell, or Hold?
Can this struggling healthcare specialist turn things around?
Mindfully Curated
Can this struggling healthcare specialist turn things around?
On this episode of FYI, Associate Portfolio Manager Nicholas Grous, ARK Advisor Angie Dalton and Analyst Andrew Kim, speak with Joe Ferencz, CEO and founder of Gamefam.
Are you ahead of the typical American worker?
These two companies are on track to benefit from the adoption of AI in big industries.
You’d struggle to find a better-performing investment.
Nvidia’s shares returned an average 78% annually over the past five years.
Can a business this mature still be a buy?
TSM earnings call for the period ending March 31, 2024.
The biotech just added another potential growth driver to its pipeline.
We also take a look at the world of activist investors and go over Jamie Dimon’s annual letter.
The renewable energy company offers a huge 12% dividend yield, but will it last?
Vanguard funds are prized for their rock-bottom expense ratios and top performance. These three funds are among the company’s best options in the large-cap growth arena.
This troubled airline enterprise might be catching the attention of deep-value investors.
Management’s annual shareholder letter detailed Amazon’s expected path to growth.
Microsoft’s free cash flow is underwhelming, and its stock costs too much.
Berkshire Hathaway is buying back billions of dollars of it shares. Don’t expect it to stop anytime soon.
For growth investors seeking exposure to the burgeoning cryptocurrency market, there’s no better option than Coinbase.
Check out James Rhee’s story.
A company is more than its numbers. The qualitative characteristics, assumptions and perceptions, and the environment itself all matter.
These companies are crushing it in AI, but one is trading at a much better value.